Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings

NCT03367234 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-06-21

No results posted yet for this study

Summary

This study evaluates the effectiveness of integrating empirically-supported treatments for an opioid use disorder into a primary care setting. These treatments will include ASAM Criteria multidimensional assessment, cognitive behavioral therapy and relapse prevention with contingency management, medication-assisted treatment, and recovery support services. Half of participants will be assigned to opioid use disorder treatment in a federally qualified health center, and half will receive treatment at a publicly-funded intensive outpatient addiction treatment program which has the ability to offer medication-assisted treatment.

Conditions

Interventions

BEHAVIORAL

Individual Therapy Sessions

One-on-one sessions with a counselor

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

Cognitive Behavioral Therapy techniques delivered by a behavioral health consultant (BHC)

BEHAVIORAL

Medication-Assisted Treatment

Buprenorphine or Extended-Release Naltrexone

BEHAVIORAL

Peer Recovery Specialist Support

Individual and/or group sessions with a certified peer recovery specialist

BEHAVIORAL

Group Therapy Sessions

Group therapy sessions

BEHAVIORAL

Psychiatric Consultation

Access to psychiatric consultation

BEHAVIORAL

Contingency Management

Rewards for engagement in specified recovery behaviors

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Public Health Management Corporation

    lead OTHER

Principal Investigators

  • David R Gastfriend, MD · Public Health Management Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2022-06-30
Completion
2022-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03367234 on ClinicalTrials.gov